Skip to content
Screener

Reported August 10, 2026 · After market close

Revenue$8.2MBeat by $619.0K
EPS-$0.64Beat by $0.03
Revenue estimate$7.6M
EPS estimate-$0.67

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$8.4M
EPS estimate-$0.45

FAQ

When did Bionano Genomics, Inc. report Q2 2026 earnings?
Bionano Genomics, Inc. (BNGO) reported Q2 2026 earnings on August 10, 2026 after market close.
What were Bionano Genomics, Inc.'s Q2 2026 revenue and EPS?
Bionano Genomics, Inc. reported revenue of $8.2M and eps of $-0.64 for Q2 2026.
Did Bionano Genomics, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $7.6M by $619.0K. EPS beat the consensus estimate of $-0.67 by $0.03.
How did Bionano Genomics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.4% from $6.7M a year earlier and eps grew 67.8% from $-1.99.
Where can I find Bionano Genomics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001411690-26-000043) and the 10-Q periodic report (0001411690-26-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.